Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Operating Profit Margin
since 2005

Microsoft Excel

Paying user area

Try for free

Abbott Laboratories pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, operating profit margin, long-term trends, calculation

Microsoft Excel
Operating profit margin = 100 × Operating earnings1 ÷ Net sales1
Dec 31, 2024 = 100 × ÷
Dec 31, 2023 = 100 × ÷
Dec 31, 2022 = 100 × ÷
Dec 31, 2021 = 100 × ÷
Dec 31, 2020 = 100 × ÷
Dec 31, 2019 = 100 × ÷
Dec 31, 2018 = 100 × ÷
Dec 31, 2017 = 100 × ÷
Dec 31, 2016 = 100 × ÷
Dec 31, 2015 = 100 × ÷
Dec 31, 2014 = 100 × ÷
Dec 31, 2013 = 100 × ÷
Dec 31, 2012 = 100 × ÷
Dec 31, 2011 = 100 × ÷
Dec 31, 2010 = 100 × ÷
Dec 31, 2009 = 100 × ÷
Dec 31, 2008 = 100 × ÷
Dec 31, 2007 = 100 × ÷
Dec 31, 2006 = 100 × ÷
Dec 31, 2005 = 100 × ÷

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

The financial data reveals several notable trends over the analyzed period concerning operating earnings, net sales, and operating profit margin.

Operating Earnings
Operating earnings exhibit considerable fluctuations throughout the years. Initial values start reasonably high at 4,362 million US dollars in 2005 but experience a sharp decline in 2006 to 2,042 million. Subsequently, earnings recover and peak at 8,085 million in 2012. After 2012, a significant drop is observed in 2013 and 2014 with earnings near 2,600 million, followed by a gradual increase reaching a subsequent peak of 8,425 million in 2021. The latest years show a moderate decline, with earnings at 6,825 million in 2024. Overall, the pattern indicates volatility with distinct peaks around 2012 and 2021 and troughs in the early 2010s and mid-2010s.
Net Sales
Net sales demonstrate a general upward trend from 22,338 million US dollars in 2005 to a peak of 43,653 million in 2022. The growth is relatively steady, although there is a dip in 2013 and 2014, dropping below 21,000 million, before resuming growth again. The largest years show consistent expansion, particularly from 2015 onwards, with only a slight decline noted in 2023, then a modest recovery in 2024. The trend suggests overall business growth with occasional downturns possibly linked to broader market or internal company cycles.
Operating Profit Margin
The operating profit margin shows significant variability. It begins at a robust 19.53% in 2005, decreases sharply to 9.09% in 2006, and later fluctuates between roughly 6% and 20%. Notable declines occur in 2013 and 2017, where margin falls to 12.03% and 6.30% respectively. After 2017, margins improve steadily, peaking near 19.56% in 2021 and slightly declining thereafter. These variations in margin reflect changes in operational efficiency or cost management relative to net sales and operating earnings, indicating cycles of profitability challenges and recoveries.

In summary, the data reveals a pattern of cyclical performance characterized by periods of growth and contraction. Despite volatility in earnings and margins, net sales maintain a generally positive trajectory, indicating underlying business expansion. Margins and earnings trends suggest sensitivity to operational factors and external economic conditions that affect profitability alongside sales growth.

Comparison to Competitors

Abbott Laboratories, operating profit margin, long-term trends, comparison to competitors

Microsoft Excel
Abbott Laboratories CVS Health Corp. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).